Clinical trial
A Prospective Study of Episcleral Brachytherapy for the Treatment of Neovascular Age-related Macular Degeneration
NCT02988895 is registered in ClinicalTrials.gov with Salutaris Medical Devices, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study of Episcleral Brachytherapy for the Treatment of Neovascular Age-related Macular Degeneration
- Lead sponsor
- Salutaris Medical Devices, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2017
- Completion date
- May 31, 2025
- Enrollment
- 11 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
macular degeneration, choroidal neovascularization